Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project).
Steffen Flindt NielsenCamilla Lundgreen DuusNiels Henrik BuusJesper Nørgaard BechFrank Holden MosePublished in: JMIR research protocols (2024)
DERR1-10.2196/56067.